Wells Fargo
BIOA

Wells Fargo’s BioAge Labs BIOA Stock Holding History

Wells Fargo’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$728K Buy
29,694
+18,288
+160% +$330K ﹤0.01% 4339
2026
Q1 		$199K Sell
11,406
-15,191
-57% -$293K ﹤0.01% 4704
2025
Q4 		$352K Buy
26,597
+6,709
+34% +$59.5K ﹤0.01% 4726
2025
Q3 		$117K Buy
19,888
+4,665
+31% +$21.8K ﹤0.01% 5241
2025
Q2 		$62.9K Buy
15,223
+8,778
+136% +$35.4K ﹤0.01% 5427
2025
Q1 		$24.2K Buy
6,445
+143
+2% +$661 ﹤0.01% 5648
2024
Q4 		$36.5K Buy
+6,302
New +$109K ﹤0.01% 5581

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Wells Fargo's BIOA Position: Q2 2026 in Review

Wells Fargo increased its BioAge Labs (BIOA) stake by 160% in Q2 2026, buying an estimated $330K and bringing the position to 29,694 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #4339.

Wells Fargo first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Wells Fargo held 29,694 shares of BioAge Labs worth $728K as of Q2 2026.
  • Wells Fargo bought 18,288 BioAge Labs shares in Q2 2026, an estimated $330K.
  • BioAge Labs made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4339 holding.
  • Wells Fargo first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.